257 related articles for article (PubMed ID: 16407989)
1. Molecular basis of inverse agonism in a G protein-coupled receptor.
Vilardaga JP; Steinmeyer R; Harms GS; Lohse MJ
Nat Chem Biol; 2005 Jun; 1(1):25-8. PubMed ID: 16407989
[TBL] [Abstract][Full Text] [Related]
2. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells.
Vilardaga JP; Bünemann M; Krasel C; Castro M; Lohse MJ
Nat Biotechnol; 2003 Jul; 21(7):807-12. PubMed ID: 12808462
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.
Zürn A; Zabel U; Vilardaga JP; Schindelin H; Lohse MJ; Hoffmann C
Mol Pharmacol; 2009 Mar; 75(3):534-41. PubMed ID: 19106230
[TBL] [Abstract][Full Text] [Related]
4. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
Prather PL
Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
6. Inverse agonism: more than reverting constitutively active receptor signaling.
Dupré DJ; Rola-Pleszczynski M; Stanková J
Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of inverse agonists for G-protein-coupled receptors.
Soudijn W; van Wijngaarden I; Ijzerman AP
Med Res Rev; 2005 Jul; 25(4):398-426. PubMed ID: 15816047
[TBL] [Abstract][Full Text] [Related]
8. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors.
Lohse MJ; Nikolaev VO; Hein P; Hoffmann C; Vilardaga JP; Bünemann M
Trends Pharmacol Sci; 2008 Mar; 29(3):159-65. PubMed ID: 18262662
[TBL] [Abstract][Full Text] [Related]
9. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling.
Vilardaga JP; Nikolaev VO; Lorenz K; Ferrandon S; Zhuang Z; Lohse MJ
Nat Chem Biol; 2008 Feb; 4(2):126-31. PubMed ID: 18193048
[TBL] [Abstract][Full Text] [Related]
10. Multiple switches in G protein-coupled receptor activation.
Ahuja S; Smith SO
Trends Pharmacol Sci; 2009 Sep; 30(9):494-502. PubMed ID: 19732972
[TBL] [Abstract][Full Text] [Related]
11. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor.
Galandrin S; Oligny-Longpré G; Bonin H; Ogawa K; Galés C; Bouvier M
Mol Pharmacol; 2008 Jul; 74(1):162-72. PubMed ID: 18403719
[TBL] [Abstract][Full Text] [Related]
12. Conformational complexity of G-protein-coupled receptors.
Kobilka BK; Deupi X
Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
14. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
16. Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.
Bhattacharya S; Vaidehi N
J Am Chem Soc; 2010 Apr; 132(14):5205-14. PubMed ID: 20235532
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.
Milligan G
Mol Pharmacol; 2003 Dec; 64(6):1271-6. PubMed ID: 14645655
[TBL] [Abstract][Full Text] [Related]
18. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
D'Aoust JP; Tiberi M
Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
[TBL] [Abstract][Full Text] [Related]
19. Sensing G protein-coupled receptor activation.
Ambrosio M; Zürn A; Lohse MJ
Neuropharmacology; 2011 Jan; 60(1):45-51. PubMed ID: 20727363
[TBL] [Abstract][Full Text] [Related]
20. Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors.
Prinster SC; Holmqvist TG; Hall RA
J Pharmacol Exp Ther; 2006 Sep; 318(3):974-81. PubMed ID: 16757535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
